YCBD
cbdMD, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 2 trimmed or exited.
- AnalystsBEARISH
0 of 6 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate −$0.030 → −$0.090 over 90 days. 0 up, 1 down in 30 days.
- Short sellersBUILDING
Short interest +19.6% to 611.1K shares. 1.0 days to cover, ≈5.5% of shares.
- TrendDOWNTREND
20% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | DOUBLED | $80.5K |
| JANE STREET GROUP, LLC | TRIM | $36.6K |
| UBS Group AG | NEAR_EXIT | $14.5K |
| UBS Group AG | DOUBLED | $122.2K |
| JANE STREET GROUP, LLC | ADD | $56.6K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | ADD | $111.00 |
| Farther Finance Advisors, LLC | ADD | $2.00 |
| VANGUARD GROUP INC | ADD | $132.6K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
6 analystsPrice is below the lowest target. Median implies +456%.Targets as of Aug 15, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 17, 2026 | Maxim Group DOWNGRADE | Hold |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 14, 2026 | Raines William F III Director | AWARD | 1,572 sh |
| Apr 14, 2026 | Stephen Scott G. Director | AWARD | 1,572 sh |
| Apr 14, 2026 | Sellers Bakari T. Director | AWARD | 1,572 sh |
| Apr 14, 2026 | Swift Sibyl Nichole Director | AWARD | 1,572 sh |
| Apr 14, 2026 | Roe Kevin Charles Director | AWARD | 1,572 sh |
| Apr 14, 2026 | Porter Jeffrey H Director | AWARD | 1,572 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.09 | -$0.09–-$0.09 | -200.0% | $5.7M |
| Next Q | -$0.06 | -$0.06–-$0.06 | — | $6.3M |
| Current FY | -$0.33 | -$0.33–-$0.33 | -73.7% | $21.9M |
| Next FY | -$0.19 | -$0.19–-$0.19 | -171.4% | $28.6M |
Short side
FINRA· Sep 30, 2026SecBot reports
3 filings · 1 press release · 0 bullish · 0 bearish · 1 mixed · 2 neutral- BULLISH PRESS RELEASESep 2, 2026
cbdMD has entered a definitive asset purchase agreement to acquire the operating assets and brands…
Monitor court approval and closing conditions for the ABC proceeding. If the deal closes, cbdMD's revenue base could more than double, significantly reducing CBD concentration risk. Watch for any…
- MIXED 8-KSep 2, 2026
cbdMD entered a definitive asset purchase agreement to acquire Twinlab's operating assets…
Monitor ABC Court proceedings for approval and any competing bids. The stalking horse protections include a 4% breakup fee (~$159K) and expense reimbursement up to $300K. If approved, the deal could…
- NEUTRAL PRESS-RELEASEAug 10, 2026
cbdMD, Inc. announced it will host a conference call on June 30, 2026 to discuss its Q3 results.
- NEUTRAL 8-KMay 20, 2026
cbdMD entered into a Third Amendment to Lease, reducing its footprint from 80,000 to 40,000 square…
The lease amendment is a routine cost-reduction measure with no material impact on the equity story. The ~$100K–$120K annual net savings is immaterial for a company with an $8M market cap. Monitor…
All YCBD filing & press-release reports (4)
- 8-K reportSep 2, 2026
- PRESS-RELEASE reportSep 2, 2026
- PRESS-RELEASE reportAug 10, 2026
- 8-K reportMay 20, 2026